SPWG
GILD icon

Sage Private Wealth Group’s Gilead Sciences GILD Stock Holding History

Sage Private Wealth Group’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-100
Closed -$6K – 167
2020
Q4 		$6K Buy
+100
New +$6.03K 0.02% 140

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Sage Private Wealth Group's GILD Position: Q1 2021 in Review

Sage Private Wealth Group sold out of Gilead Sciences (GILD) in Q1 2021, closing a stake of 100 shares — an estimated $6K sold.

Sage Private Wealth Group first reported a position in GILD in Q4 2020 and held it in 1 quarter. The position peaked at $6K in Q4 2020. 1,567 funds tracked by Wall St. Rank hold GILD as of Q1 2021.

  • Sage Private Wealth Group reported no remaining Gilead Sciences position as of Q1 2021 after selling out during the quarter.
  • Sage Private Wealth Group sold 100 Gilead Sciences shares in Q1 2021, an estimated $6K.
  • Sage Private Wealth Group first reported a position in Gilead Sciences in Q4 2020 and held it in 1 quarter.
  • Sage Private Wealth Group's Gilead Sciences position peaked at $6K in Q4 2020.
  • 1,567 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2021.

Based on Sage Private Wealth Group's 13F filing for Q1 2021, filed 18 May 2021.